Literature DB >> 7489239

Ten LDL receptor mutants explain one third of familial hypercholesterolemia in a German sample.

H Schuster1, C Keller, G Wolfram, N Zöllner.   

Abstract

Mutational defects in the LDL receptor are responsible for familial hypercholesterolemia (FH); thus far more than 150 mutations have been described. Nevertheless, systematic searches among the Germans have not been conducted. We used single-strand conformational polymorphism and polymerase chain reaction to find mutations in 10 index patients and in 40 other individuals with heterozygous FH. Our screen in the 10 index patients revealed 7 hitherto undescribed mutations. A screen of the 40 additional FH patients disclosed 20 defective of 54 total alleles and allowed specific diagnoses in 88 family members. We also found two families in which the children were markedly affected by FH, but the expected parental expression of the trait was not manifest. This observation suggests a role for additional environmental and genetic influences. Our report represents the first comprehensive effort to identify FH mutations in Germany. We found 10 mutations and these mutations explain 37% of FH cases. Our data may have relevance to expected FH patterns in central Europe.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7489239     DOI: 10.1161/01.atv.15.12.2176

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  5 in total

1.  Software and database for the analysis of mutations in the human LDL receptor gene.

Authors:  M Varret; J P Rabès; G Collod-Béroud; C Junien; C Boileau; C Béroud
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

2.  Mutations in the low-density-lipoprotein receptor gene in German patients with familial hypercholesterolaemia.

Authors:  N Weiss; G Binder; C Keller
Journal:  J Inherit Metab Dis       Date:  2000-12       Impact factor: 4.982

3.  LDLR Database (second edition): new additions to the database and the software, and results of the first molecular analysis.

Authors:  M Varret; J P Rabés; R Thiart; M J Kotze; H Baron; A Cenarro; O Descamps; M Ebhardt; J C Hondelijn; G M Kostner; Y Miyake; M Pocovi; H Schmidt; H Schuster; M Stuhrmann; T Yamamura; C Junien; C Béroud; C Boileau
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

4.  LDLR promoter variant and exon 14 mutation on the same chromosome are associated with an unusually severe FH phenotype and treatment resistance.

Authors:  Christine L H Snozek; Susan A Lagerstedt; Teck K Khoo; Melvyn Rubenfire; William L Isley; Laura J Train; Linnea M Baudhuin
Journal:  Eur J Hum Genet       Date:  2008-07-23       Impact factor: 4.246

5.  Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia.

Authors:  Xu Wang; Long Jiang; Li-Yuan Sun; Yue Wu; Wen-Hui Wen; Xi-Fu Wang; Wei Liu; Yu-Jie Zhou; Lu-Ya Wang
Journal:  J Geriatr Cardiol       Date:  2018-06       Impact factor: 3.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.